By utilizing three Cre lines, including the ubiquitous CMV-Cretg and tissue-specific Six2-TGCtg and Foxd1GC, we have demonstrated that either whole-body or kidney-specific expression of ENL tumor mutations impairs kidney development, resulting in smaller kidneys with severe structural defects and neonatal lethality. This evidence concerns the gene MLLT1 and neoplasm.